It was revealed that PHLDA1 mRNA expression was higher, which leads to a higher risk of distant metastasis in estrogen receptor (ER)-positive breast cancers, but PHLDA1 exerts the opposite effects on breast cancers that are ER-negative [19]. The gene discussed is ESR1; the disease is breast carcinoma.